Hazard ratio for HCC progression and all cause mortality, comparing untreated patients and patients who received adjuvant antiviral therapy at different time points.

*Multivariable Cox proportional hazards analyses was adjusted for sex, age, stage, tumor size, curative therapy, alcoholic liver disease, cirrhosis of liver without mention of alcohol, ascites, encephalopathy, esophageal varices, hapatorenal syndrome, congestive heart failure, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatic disease, diabetes mellitus, and renal disease.